Toggle navigation
Home
Search
Services
Blog
Contact
About
Palladium Complexes Having IN-Vivo Antitumor Activity
Gill, Devinder
Andrulis Research Corporation, Bethesda, MD, United States
Search 7 grants from Devinder Gill
Search grants from Andrulis Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Project 3
Chronic Hypoxia, Pregnancy and Systemic Vascular Control
Influence of H-2 Antigens on Mouse T Cell Responses
Functional Characterization of Sr and T-Tubule Membranes
NSF Young Investigator: Mechanism of RNA Folding by Disulfide Bond Trapping of Folding Intermediates
Recently added grants:
Pharmacological Npt2a inhibition as a treatment for hyperphosphatemia in chronic kidney disease
Validation of Swine Model for Testing a Novel Therapy for Postoperative Atrial Fibrillation using Nanoformulated Calcium Chloride to Suppress Cardiac Ganglionated Plexi
Role of nitro-fatty acids in BBB stabilization and post-stroke neurovascular protection
Quantitative genetic approaches to Candida albicans oropharyngeal pathogenesis
Roles of STING and innate lymphoid cell plasticity in severe asthma
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM057819-000
Application #
3613434
Study Section
Project Start
1985-09-30
Project End
Budget Start
1985-09-30
Budget End
1986-03-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Andrulis Research Corporation
Department
Type
DUNS #
City
Bethesda
State
MD
Country
United States
Zip Code
20814
Related projects
NIH 1986
N43 CM
Palladium Complexes Having IN-Vivo Antitumor Activity
Gill, Devinder / Andrulis Research Corporation
NIH 1985
N43 CM
Palladium Complexes Having IN-Vivo Antitumor Activity
Gill, Devinder / Andrulis Research Corporation
Comments
Be the first to comment on Devinder Gill's grant